2020 Annual Course eBundle
(all four Annual Course eModules for the price of three, denoted with an *asterisk) 
| - Members: $149
- Non-members: $209
|
Weaning Antiseizure Medications | 1.0 AMA PRA Category 1 Credit™ | $19 for members, $29 for non-members
Starting with a review of the American Academy of Neurology 2021 Practice Advisory, this self-paced, interactive course offers a practical framework for if, when, and how to wean patients off antiseizure medications. Participants are guided through realistic patient scenarios that demonstrate how to use patient data and current research to determine patient readiness for medication withdrawal.
Neurocognitive Disabilities: A Best Practice Overview of Care (content sourced from the AES2020 Best Practices Symposium) | 2.5 AMA PRA Category 1 Credits™ | $49 for members, $69 for non-members
Focuses on care information for patients with neurocognitive and disabilities. Case study examples will include Autism Spectrum Disorder, Angelman Syndrome, and Dravet Syndrome.
*Diagnosis of New Onset Epilepsy (content sourced from the AES2020 Annual Course) 1.5 AMA PRA Category 1 Credits™| $49 for members, $69 for non-members
Explores current advances in the diagnosis
of new-onset epilepsy.
*Treatment of New Onset Epilepsy (content sourced from the AES2020 Annual Course) 1.5 AMA PRA Category 1 Credits™| $49 for members, $69 for non-members
Explores current advances in the treatment
of new-onset epilepsy. Experts will cover treatment of new onset epilepsy and address genetic testing and psychogenic non-epileptic seizures (PNES).
*Diagnosis of Drug Resistant Epilepsy (content sourced from the AES2020 Annual Course) 1.5 AMA PRA Category 1 Credits™| $49 for members, $69 for non-members
Explores current advances in the
diagnosis of drug-resistant epilepsies. Experts will cover treatment and diagnostic issues related to drug-resistant epilepsy such as gene therapy, wearables, and autoimmune evaluation.
*Treatment of Drug Resistant Epilepsy (content sourced from the AES2020 Annual Course) 1.5 AMA PRA Category 1 Credits™| $49 for members, $69 for non-members
Explores current advances in the
treatment of drug-resistant epilepsy. Experts will cover treatment of drug-resistant epilepsy including surgery in older adults, new anti-seizure medications, and psychiatric and cognitive outcomes of epilepsy surgery.
*The American Epilepsy Society designates these enduring activities for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AKH Inc., Advancing Knowledge in Healthcare designates these education activities for a maximum of 8.50 contact hours.
Free to Members and Non-members:
Anxiety in Epilepsy (2021), 1.50 AMA PRA Category 1 Credit™, Free
This module is designed to enhance clinicians' skills in identifying and managing anxiety
in children and adults with epilepsy. It covers epidemiology, diagnosis, and treatment and aims to bridge the management gap by providing practical use cases and education for clinicians.
The American Epilepsy Society designates this enduring
activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.